Intestinal bacteria butyribacterintestini and application thereof
US11033614B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2016 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Oct 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N1/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an application of Butyribacter intestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.